EGFR and AIDS dementia complex: The best known of these are the EGFR tyrosine kinase inhibitors such as erlotinib and osimertinib, which have proved effective for EGFR mutant ADC tumors (Hirsch et al., 2017; Winther-Larsen et al., 2019).